Related Experiment Video
Updated: May 13, 2026
06:16
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Cost-effectiveness analysis: role and implications
1National Clinical Guideline Centre, Royal College of Physicians, 11 St Andrews Place, Regent's Park, London NW1 4LE, UK. grace.marsden@rcplondon.ac.uk
Phlebology
|March 14, 2013
Summary
Cost-effectiveness analysis (CEA) maximizes population health gains within budget limits, not by cutting costs. It guides healthcare decisions, ensuring optimal value, as demonstrated by varicose vein treatment evaluations.
Area of Science:
- Health Economics
- Public Health Policy
Background:
- Cost-effectiveness analysis (CEA) is often misunderstood as a cost-cutting measure.
- CEA aims to maximize health gains within financial constraints, crucial for healthcare decision-making due to budget limitations.
Purpose of the Study:
- To explain the role and principles of CEA in healthcare systems.
- To illustrate CEA's application using varicose vein treatment in the UK's NHS.
- To demonstrate how CEA can optimize health outcomes and resource allocation.
Main Methods:
- Review of current literature on the cost-effectiveness of varicose vein treatment.
- Explanation of core CEA concepts: economic modeling, incremental cost-effectiveness ratios (ICERs), net monetary benefit (NMB), and sensitivity analysis.
- Application of these concepts to varicose vein treatment scenarios.
Main Results:
- Varicose vein treatment is often not commissioned locally due to misperception as cosmetic, neglecting quality of life impacts.
- CEA can quantitatively balance treatment costs against health-related quality of life, informing commissioning decisions.
- CEA provides a framework to compare different varicose vein treatments and identify efficiencies.
Conclusions:
- CEA is a valuable tool for maximizing population health under budget constraints, contrary to cost-cutting perceptions.
- CEA can effectively evaluate the cost-effectiveness of various varicose vein treatments.
- Implementing CEA can lead to realized efficiencies in healthcare resource allocation.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:15Methods of Documentation VI: Case Management Model
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
For example, a patient with a chronic illness...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:09Decision Making: P-value Method
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
01:30Health Information Technology and Healthcare Information System
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
01:16Bioequivalence Data: Statistical Interpretation
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...